Adjuvant TACE in HCC With High-risk Recurrence Factors

Clinical trial NCT07417397 · RECRUITING

Trial details

NCT number: NCT07417397
Sponsor: Guangxi Medical University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Adjuvant Transarterial Chemoembolization

Start date: 2026-02-01
Primary completion: 2029-12-31
Enrollment: 442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.